Month: January 2026

Dyne Therapeutics, Inc. (DYN) Presents at 44th Annual J.P. Morgan Healthcare Conference – Slideshow

Market Premium For 10-Year Yield Holds Near Fair Value Estimate

Robert MarcusJPMorgan Chase & Co, Research Division Good afternoon, everyone. I’m Robbie Marcus, the MedTech analyst at JPMorgan. Really happy to present Merit Medical. We have new CEO, Martha Aronson. Martha is going to give […]